# Sodium Valproate for GSDV

> **NCT03112889** · PHASE2 · COMPLETED · sponsor: **University College, London** · enrollment: 8 (estimated)

## Conditions studied

- Glycogen Storage Disease Type V
- McArdle Disease

## Interventions

- **DRUG:** Sodium Valproate

## Key facts

- **NCT ID:** NCT03112889
- **Lead sponsor:** University College, London
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2017-04-05
- **Final completion:** 2017-04-05
- **Target enrollment:** 8 (ESTIMATED)
- **Last updated:** 2018-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03112889

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03112889, "Sodium Valproate for GSDV". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT03112889. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*